Crossmark

Neuroligin-2-derived peptide-covered polyamidoamine-based (PAMAM) dendrimers enhance pancreatic β-cells' proliferation and functions

Crossref DOI link: https://doi.org/10.1039/C8MD00419F

Published Online: 2019

Update policy: https://doi.org/10.1039/rsc_crossmark_policy

Authors

Munder, Anna

Moskovitz, Yoni

Meir, Aviv

Kahremany, Shirin

Levy, Laura

Kolitz-Domb, Michal

Cohen, Guy https://orcid.org/0000-0002-9608-1081
Shtriker, Efrat

Viskind, Olga

Lellouche, Jean-Paul

Senderowitz, Hanoch https://orcid.org/0000-0003-0076-1355
Chessler, Steven D.

Korshin, Edward E. https://orcid.org/0000-0002-6318-9942
Ruthstein, Sharon https://orcid.org/0000-0002-1741-6892
Gruzman, Arie https://orcid.org/0000-0002-8006-4201
Funding

Funding for this research was provided by:

Bar-Ilan University

Israel Science Foundation (117/2014)

Wolf Foundation

National Institutes of Health (R01DK080971)

National Institute of Diabetes and Digestive and Kidney Diseases (R01DK080971)

Ministry of Science and Technology, Israel

Seventh Framework Programme (FP7-530)
License Information

Accepted Manuscript valid from 2019-12-13
More Information

SIMILARITY CHECK

: This document is Similarity Check deposited

RELATED DATA

: Supplementary Information

IDENTIFIERS

: Guy Cohen (ORCID)

: Hanoch Senderowitz (ORCID)

: Edward E. Korshin (ORCID)

: Sharon Ruthstein (ORCID)

: Arie Gruzman (ORCID)

PEER REVIEW METHOD

: Single-blind

PUBLICATION HISTORY

: Received 28 August 2018; Accepted 11 December 2018; Accepted Manuscript published 13 December 2018; Advance Article published 16 January 2019; Version of Record published 20 February 2019